BUSINESS

• MSD Paid 19.4 Billion Yen to Healthcare Professionals in 2013
  September 25, 2014

• Gilead Sciences Submits NDA for Ledipasvir/Sofosbuvir Combination for Genotype 1 Chronic Hepatitis C
  September 25, 2014

• AnGes MG to Start Collategene Administration in PIII Study in US as Early as October
  September 25, 2014

• Ibandronate Oral Agent to Be Filed for Japan Approval in 2015: Chugai, Taisho
  September 24, 2014

• Meiji Seika Pharma Seeks New Indication for Laserphyrin
  September 24, 2014

• Mediceo Sets to Increase Qualified Reps to 2,000, Enter Contract PMS Biz within 3 Years
  September 22, 2014

• Bristol-Myers Submits NDA for Malignant Melanoma Drug Ipilimumab
  September 22, 2014

• Additional Indication Approved for MTPC’s Telavic
  September 22, 2014

• RaQualia Wins Use-Patent Allowance for EP4 Antagonist in US
  September 22, 2014

• Bayer’s Japan Open Innovation Center Now Up and Running
  September 22, 2014

• Sadao Furuichi to Double as Heads of Kracie Pharma, Kracie Pharmaceutical
  September 22, 2014

• Huya Bioscience International Opens Tokyo Office
  September 19, 2014

• MTPC Generic Arm Seeks to Quickly Broaden Product Lineup, New Alliance a Possibility: Pres.
  September 18, 2014

• Takeda to Reshuffle Global Structure in April
  September 18, 2014

• Toray Partners with German Firm on Sales of Hemoperfusion Device in Europe
  September 18, 2014

• Allergan, Shionogi Tie Up for Sales of Eyelash Hypotrichosis Agent
  September 18, 2014

• Bayer Paid 10.1 Billion Yen to Healthcare Professionals in 2013
  September 18, 2014

• Bristol-Myers’ 2013 Payments to Health Professionals Total 4.9 Billion Yen
  September 18, 2014

• Eisai Inks Two Joint Research Deals for Novel Antimalarial Agents
  September 18, 2014

• Kaketsuken Wins Grants for Dengue Vaccine Program from GHIT Fund
  September 18, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 547
• 548
• 549
• 550
• 551
• 552
• 553
• 554
• 555
• …
• Next ›
• 最終 »